关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nicpbp.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  4 2 9 8 4 4 8 位浏览者
您当前的位置:首页 >> 正文

螨变应原注射液体外效力评价方法的建立及验证

Establishment and validation of in vitro potency assay method for mite allergen injection

作者(英文):
分类号:R917
出版年·卷·期(页码):2019,39 (3):406-412
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的:针对铝佐剂吸附的螨变应原注射液缺乏有效的生物效力评价方法的现状,探索用基于ImmunoCAP仪的荧光酶联免疫分析方法(ImmunoCAP法)作为该制品体外效力评价方法可行性,以促进该制品质量标准的提高。方法:利用ImmunoCAP法测定螨变应原注射液对过敏病人血清中IgE的抑制率(又称为变应原活性),作为该制品效力评价的检测指标。研究中分析了该方法的特异性;探索了孵育时间、温度、血清稀释度、变应原浓度等条件对抑制率的影响;验证了该方法的精密性;测定了13批维持剂量螨变应原注射液的总变应原活性和上清游离变应原活性。结果:应用ImmuonCAP法测定维持剂量螨变应原注射液对过敏病人血清IgE抑制率,具有较好的特异性;维持剂量制品对血清中特异性IgE的抑制率与变应原浓度具有明显的量效反应关系;该法具有很好的精密性,RSD最大不超过5%;13批维持剂量制品总变应原对血清中IgE抑制率均大于50%;上清中游离变应原对血清中IgE抑制率均不高于20%。结论:ImmunoCAP法可用于铝佐剂吸附的螨变应原注射液的体外效力评价,重复性好,精密度高,操作简便。

-----英文摘要:---------------------------------------------------------------------------------------

Objective: To discuss the feasibility of a fluorescence ELISA method based on ImmunoCAP ® for in vitro potency evaluation of mite allergen injection absorbed in view of the lack of effective evaluation method for the mite allergen injection adsorbed by aluminum adjuvant in order to improve the quality standard of the products. Methods: The inhibition rate of IgE in serum of allergic patients (also known as allergen activity) was determined by ImmunoCAP as the evaluation indicator of in vitro potency. The specificity of the method was analyzed. The effects of parameters such as incubation time, temperature, serum dilution and allergen concentration on inhibition rate were investigated. The precision of the method was verified. The total allergen activity and the free allergen activity of supernatant were determined in 13 batches of mite allergens injections of maintenance dose. Results: The specificity of the inhibition rate of IgE in serum of allergic patients of maintenance dose of mite allergen injection determined by ImmunoCAP was good. The inhibitory rate of the specific IgE in the serum of the maintenance dose preparation has a significant dose-response relationship with the allergen concentration. The method had good precision and the maximum RSD was no more than 5%. The inhibition rate of IgE in serum of the total allergen of 13 batches of maintenance dose was more than 50%. The inhibitory rate of IgE in serum of the free allergen in the supernatant was no more than 20%. Conclusion: The ImmunoCAP method can be used for in vitro potency evaluation of the mite allergen injection adsorbed by aluminum adjuvant,with good repeatability, high precision and easy operation.

-----参考文献:---------------------------------------------------------------------------------------

[1] THOMAS WR,HALES BJ,SMITH WA. House dust mite allergens in asthma and allergy[J]. Trends Mol Med,2010, 16(7):321
[2] LEE KS, YUM HY, SHEEN YH, et al. Comorbidities and phenotypes of rhinitis in Korean children and adolescents:a crosssectional, multicenter study[J]. Allergy Asthma Immunol Res, 2017, 9(1):70
[3] CALDERON MA, LINNEBERG A, KLEINE-TEBBE J, et al. Respiratory allergy caused by house dust mites:what do we really know[J]. J Allergy Clin Immunol,2015, 136(1):38
[4] LEE JH, KIM SC, CHOI H, et al. A retrospective study of clinical response predictors in subcutaneous allergen immunotherapy With house dust Mites for Allergic Rhinitis[J]. Allergy Asthma Immunol Res, 2018, 10(1):18
[5] BOZEK A, KOLODZIEJCZY K, KLZLWOSKA R, et al. Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients:a randomized, double-blind placebo-controlled trial[J]. Clin Transl Allergy, 2017,7(1):811
[6] CARNES J,IRAOLA V,CHO SH,et al. Mite allergen extracts and clinical practice[J]. Ann Allergy Asthma Immunol,2017,118(3):249
[7] ZIMMER J, VIETHS S, KAUL S. Standardization and regulation of allergen products in the European Union[J]. Curr Allergy Asthma Rep, 2016, 16(3):21
[8] van HAGE M, HAMSTEN C, VALENTA R. ImmunoCAP assays:Pros and cons in allergology[J]. J Allergy Clin Immunol,2017,140(4):974
[9] CARNES J, IRAOLA V, GALLEGO M, et al. Control process for manufacturing and standardization of allergenic molecules[J]. Curr Allergy Asthma Rep,2015, 15(7):37
[10] SPIRIC J, REUTER A, RABIN RL. Mass spectrometry to complement standardization of house dust mite and other complex allergenic extracts[J]. Clin Exp Allergy,2017, 47(5):604
[11] 王春娥,石继春,王珊珊,等. 屋尘螨变应原制品活性测定方法的建立[J]. 药物分析杂志),2013, 33(5):775 WANG CE, SHI JC, WANG SS, et al. Bioactivity detection method for Dermatophagoides pteronyssinus products[J]. Chin J Pharm Anal, 2013, 33(5):775
[12] 石继春,王春娥,王珊珊,等. 屋尘螨变应原制剂质量标准的研究[J]. 中国药事, 2014, 28(6):622 SHI JC,WANG CE,WANG SS,et al. Study of quality standards of mites allergens ALK D. P[J]. Chin Pharm Aff,2014, 28(6):622

欢迎阅读《药物分析杂志》!您是该文第 269位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn

本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838